Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Intravenous immunoglobulin: adverse reactions and management.

Bonilla FA.

J Allergy Clin Immunol. 2008 Dec;122(6):1238-9. doi: 10.1016/j.jaci.2008.08.033. Epub 2008 Oct 8. Review. No abstract available.

PMID:
18842292
2.

Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema.

Binitha MP, Nandakumar G, Thomas D.

Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):248-50.

3.

[Human immunoglobulins, adverse drug reaction, prevention].

Grenouillet-Delacrea M, Longy-Boursier M.

Rev Med Interne. 2008 Jun;29 Spec No 2:24-8. Review. French.

PMID:
18927984
4.

Intravenous immunoglobulin induced meningoencephalitis.

Nooraine J, Iyer RB, Raghavendra S.

Neurol India. 2014 Jan-Feb;62(1):98-9. doi: 10.4103/0028-3886.128354. No abstract available.

5.

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.

Shiraishi T, Yamamoto T.

Pediatr Dermatol. 2013 May-Jun;30(3):e30-1. doi: 10.1111/j.1525-1470.2011.01717.x. Epub 2012 Feb 3.

PMID:
22304420
6.

Clinically significant pseudohyponatremia.

Bern M.

Am J Hematol. 2006 Jul;81(7):558-9. No abstract available.

7.

Occurrence of anti-HPA-5b alloantibodies during intravenous immunoglobulin treatment in an HPA-15b alloimmunised woman: a case report.

Moncharmont P, Makowski C, Equy V, Andrini P, Rigal D.

Transfus Med. 2013 Jun;23(3):202-3. doi: 10.1111/tme.12015. Epub 2013 Feb 12. No abstract available.

PMID:
23402651
8.

Hyperhaemolysis in a patient with HbH disease.

Danaee A, Howard J, Robertson B, Robinson S.

Transfus Med. 2014 Aug;24(4):244-5. doi: 10.1111/tme.12131. Epub 2014 Jun 23. No abstract available.

PMID:
24957792
9.

Intravenous immunoglobulin-associated vena cava thrombosis.

Marie I, Hervé F, Kerleau JM, Maurey G, Levesque H.

Thromb Haemost. 2006 Dec;96(6):849-51. No abstract available.

PMID:
17139383
10.

Intravenous immunoglobulin-induced reversible neutropenia in a renal transplant patient.

Singh A, Arif F, Smith SD.

Clin Nephrol. 2005 Sep;64(3):246-8. No abstract available.

PMID:
16175954
11.

Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.

Ettler J, Arenberger P, Arenbergerova M, Gkalpakiotis S.

J Eur Acad Dermatol Venereol. 2016 Feb;30(2):355-6. doi: 10.1111/jdv.12767. Epub 2014 Oct 20. No abstract available.

PMID:
25327640
12.

Intravenous immunoglobulin for pyoderma gangrenosum.

Kreuter A, Reich-Schupke S, Stücker M, Altmeyer P, Gambichler T.

Br J Dermatol. 2008 Apr;158(4):856-7. doi: 10.1111/j.1365-2133.2007.08433.x. Epub 2008 Jan 30. No abstract available.

PMID:
18241257
13.

Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome.

Young PK, Ruggeri SY, Galbraith S, Drolet BA.

Arch Dermatol. 2006 Feb;142(2):247-8. No abstract available.

PMID:
16490861
14.

Impairment of renal function after intravenous immunoglobulin.

Soares SM, Sethi S.

Nephrol Dial Transplant. 2006 Mar;21(3):816-7. Epub 2006 Jan 6. No abstract available.

PMID:
16399766
15.

Appropriate use of intravenous immunoglobulin in neonatal neutropenia.

Buenz EJ, Howe CL.

J Perinatol. 2007 Mar;27(3):196-7; author reply 197. No abstract available.

PMID:
17314992
16.

Giving intravenous immunoglobulin.

Scherf R, White-Reid K.

RN. 2008 Jan;71(1):29-34; quiz 35. No abstract available.

PMID:
18271361
17.

Recommended indications for the administration of polyclonal immunoglobulin preparations.

Delforge M, Farber CM, Spath P, Kaveri S, Witte T, Misbah SA, Hübner R, Haerynck F, Latinne D, Muylle L, Toungouz M, Deneys V; Superior Health Council Belgium.

Acta Clin Belg. 2011 Sep-Oct;66(5):346-60.

PMID:
22145269
18.

Human intravenous immunoglobulin-induced aseptic meningitis: a case report.

Chaabane A, Hamzaoui A, Aouam K, Klai R, Fredj NB, Boughattas NA, Mahjoub S.

J Clin Pharmacol. 2012 Feb;52(2):279-81. doi: 10.1177/0091270010394183. No abstract available.

PMID:
21257801
19.

[Immunoglobulins and immune deficiency: methods of administration].

Suarez F.

Rev Med Interne. 2005 Oct;26 Spec No 1:25-8. French. No abstract available.

PMID:
16475260
20.

Successful treatment of cutaneous lesions in juvenile dermatomyositis with high-dose intravenous immunoglobulin.

Amano H, Nagai Y, Katada K, Hashimoto C, Ishikawa O.

Br J Dermatol. 2007 Jun;156(6):1390-2. Epub 2007 Apr 25. No abstract available.

PMID:
17459039

Supplemental Content

Support Center